Joseph H. Perriëns

1.8k total citations
30 papers, 1.2k citations indexed

About

Joseph H. Perriëns is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Joseph H. Perriëns has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Economics and Econometrics. Recurrent topics in Joseph H. Perriëns's work include HIV/AIDS Research and Interventions (15 papers), Tuberculosis Research and Epidemiology (8 papers) and HIV Research and Treatment (5 papers). Joseph H. Perriëns is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), Tuberculosis Research and Epidemiology (8 papers) and HIV Research and Treatment (5 papers). Joseph H. Perriëns collaborates with scholars based in Switzerland, United States and Belgium. Joseph H. Perriëns's co-authors include Kenrad E. Nelson, Khuanchai Supparatpinyo, Thira Sirisanthana, Joan Kaufman, Yves Souteyrand, Peter Piot, Marco Vitória, Evan Lee, Robert W. Ryder and J Prignot and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Joseph H. Perriëns

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph H. Perriëns Switzerland 18 935 658 252 147 126 30 1.2k
Gaston Djomand United States 16 1.3k 1.4× 955 1.5× 443 1.8× 78 0.5× 167 1.3× 28 1.6k
Tsehaynesh Messele Ethiopia 24 962 1.0× 609 0.9× 515 2.0× 75 0.5× 150 1.2× 64 1.8k
Jean-Michel Tassie France 12 714 0.8× 386 0.6× 436 1.7× 59 0.4× 67 0.5× 20 1.0k
Ying-Ru Lo Switzerland 19 870 0.9× 998 1.5× 150 0.6× 61 0.4× 92 0.7× 37 1.5k
Kenneth A. Freedberg United States 10 1.2k 1.3× 714 1.1× 538 2.1× 166 1.1× 137 1.1× 15 1.5k
Nzila Nzilambi United States 17 1.0k 1.1× 529 0.8× 745 3.0× 83 0.6× 72 0.6× 22 1.5k
Paul K. Drain United States 20 1.1k 1.1× 548 0.8× 255 1.0× 62 0.4× 206 1.6× 73 1.3k
Eric Lugada Uganda 14 805 0.9× 851 1.3× 226 0.9× 76 0.5× 43 0.3× 28 1.6k
Madeleine Sassan‐Morokro United States 17 950 1.0× 567 0.9× 425 1.7× 46 0.3× 176 1.4× 22 1.1k
Issa‐Malick Coulibaly United States 13 1.2k 1.3× 767 1.2× 511 2.0× 66 0.4× 191 1.5× 19 1.5k

Countries citing papers authored by Joseph H. Perriëns

Since Specialization
Citations

This map shows the geographic impact of Joseph H. Perriëns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph H. Perriëns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph H. Perriëns more than expected).

Fields of papers citing papers by Joseph H. Perriëns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph H. Perriëns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph H. Perriëns. The network helps show where Joseph H. Perriëns may publish in the future.

Co-authorship network of co-authors of Joseph H. Perriëns

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph H. Perriëns. A scholar is included among the top collaborators of Joseph H. Perriëns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph H. Perriëns. Joseph H. Perriëns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sagaon‐Teyssier, Luis, Boniface Dongmo Nguimfack, Intira Jeannie Collins, et al.. (2016). An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012. BMC Pediatrics. 16(1). 41–41. 9 indexed citations
2.
Smit, Pieter W., Kimberly A. Sollis, Susan A. Fiscus, et al.. (2014). Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis. PLoS ONE. 9(3). e86461–e86461. 108 indexed citations
3.
4.
Easterbrook, Philippa, et al.. (2014). The role of mathematical modelling in the development of recommendations in the 2013 WHO consolidated antiretroviral therapy guidelines. AIDS. 28(Supplement 1). S85–S92. 11 indexed citations
5.
Souteyrand, Yves, et al.. (2008). Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?. Globalization and Health. 4(1). 8–8. 133 indexed citations
6.
Nguimfack, Boniface Dongmo, et al.. (2007). Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens. AIDS. 21(Suppl 4). S89–S95. 80 indexed citations
7.
Vasan, Ashwin, et al.. (2006). Examining the production costs of antiretroviral drugs. AIDS. 20(13). 1745–1752. 43 indexed citations
8.
Supparatpinyo, Khuanchai, Joseph H. Perriëns, Kenrad E. Nelson, & Thira Sirisanthana. (1998). A Controlled Trial of Itraconazole to Prevent Relapse ofPenicillium marneffeiInfection in Patients Infected with the Human Immunodeficiency Virus. New England Journal of Medicine. 339(24). 1739–1743. 103 indexed citations
9.
Sirisanthana, Thira, Khuanchai Supparatpinyo, Joseph H. Perriëns, & Kenrad E. Nelson. (1998). Amphotericin B and Itraconazole for Treatment of DisseminatedPenicillium marneffeiInfection in Human Immunodeficiency Virus–Infected Patients. Clinical Infectious Diseases. 26(5). 1107–1110. 122 indexed citations
10.
Damme, Lut Van, Somchai Niruthisard, Kees Boer, et al.. (1998). Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS. 12(4). 433–437. 47 indexed citations
11.
O’Brien, Richard & Joseph H. Perriëns. (1995). Preventive therapy for tuberculosis in HIV infection. AIDS. 9(7). 665–674. 28 indexed citations
12.
Perriëns, Joseph H., et al.. (1994). Anti-A60 immunoglobulin G in the serodiagnosis of tuberculosis in HIV-seropositive and seronegative patients. AIDS. 8(9). 1277–1280. 8 indexed citations
13.
Nelson, Ann Marie, Joseph H. Perriëns, B Kapita, et al.. (1993). A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaïre. AIDS. 7(9). 1241–1246. 39 indexed citations
14.
Klausner, Jeffrey D., et al.. (1993). Mycobacterium tuberculosis in Household Contacts of Human Immunodeficiency Virus Type 1-Seropositive Patients with Active Pulmonary Tuberculosis in Kinshasa, Zaire. The Journal of Infectious Diseases. 168(1). 106–111. 34 indexed citations
15.
Perriëns, Joseph H., et al.. (1993). Low and stable HIV seroprevalence in pregnant women in Shaba province, Zaire.. PubMed. 6(4). 419–23. 9 indexed citations
16.
Heymann, Dominique, Jack J. Wirima, & Joseph H. Perriëns. (1992). Treatment, prophylaxis and research priorities for developing countries. AIDS. 7. S235–S240. 1 indexed citations
17.
Perriëns, Joseph H., et al.. (1992). Prevention of blood-borne HIV transmission using a decentralized approach in Shaba, Zaire. AIDS. 6(11). 1353–1358. 16 indexed citations
18.
19.
Colebunders, Robert, R. W. Ryder, Henry Francis, et al.. (1991). Seroconversion Rate, Mortality, and Clinical Manifestations Associated with the Receipt of a Human Immunodeficiency Virus-Infected Blood Transfusion in Kinshasa, Zaire. The Journal of Infectious Diseases. 164(3). 450–456. 45 indexed citations
20.
Perriëns, Joseph H., et al.. (1990). Prevention of transfusion-associated HIV transmission in Kinshasa, Zaire. AIDS. 4(6). 571–574. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaston Djomand Breakdown of academic impact, for papers by Tsehaynesh Messele Breakdown of academic impact, for papers by Jean-Michel Tassie Breakdown of academic impact, for papers by Ying-Ru Lo Breakdown of academic impact, for papers by Kenneth A. Freedberg Breakdown of academic impact, for papers by Nzila Nzilambi Breakdown of academic impact, for papers by Paul K. Drain Breakdown of academic impact, for papers by Eric Lugada Breakdown of academic impact, for papers by Madeleine Sassan‐Morokro Breakdown of academic impact, for papers by Issa‐Malick Coulibaly
Rankless by CCL
2026